NYSE$NEUE

NeueHealth Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Headline financials

Total Revenue

$1.11B

Previous: $495M+124.8%
EPS (adj)

-$22.40

Previous: -$15.20-47.4%
Operating Cost Ratio

23.4%

No prior period
Capital Expenditures

-$10.6M

Previous: $319K-3408.5%
Free Cash Flow

$487M

Previous: $86.7M+461.1%
Net Income

-$44.5M

Previous: -$18.1M-146.3%
Operating Income

-$59M

Previous: -$34.5M-71.1%
Gross Profit

$1.11B

Previous: $495M+124.8%
Cash & Equivalents

$1.51B

Previous: $369M+308.0%
Total Assets

$3.6B

No prior period
Stock-Based Comp

$13.9M

Previous: $2.19M+532.8%

Revenue & EPS history

NeueHealth · Revenue · Quarterly

$1.11B

Q2 2021+124.8%vs Q2 2020
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

-2.0%

Avg return

Earnings day

-6.9%

Avg return

5 days after

-17.7%

Avg return

30 days after

45%

10 / 22 earnings

Positive

+46.5%

Q1 2023

Best reaction

-43.1%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025
Q2 2025+0.0%-2.2%-2.1%
Q1 2025-2.2%-0.4%-1.5%
Q4 2024+8.9%+30.9%+29.9%
Q3 2024+2.2%+2.5%+7.8%
Q2 2024-3.6%+2.3%-4.4%
Q1 2024-4.0%-3.7%-14.3%
Q4 2023+7.6%-6.0%-27.7%
Q3 2023-1.5%-10.2%-15.5%
Q2 2023-21.8%-27.8%-61.3%
Q1 2023+46.5%+7.2%-14.1%
Q4 2022-43.1%-48.8%-77.2%
Q3 2022+4.3%-3.7%-15.3%
Q2 2022-9.3%+2.1%-15.1%
Q1 2022+35.7%+26.0%-0.6%
Q4 2019-2.6%-1.3%-16.4%
Q4 2021-29.5%-42.9%-35.6%
Q3 2020+1.3%-13.1%-15.4%
Q3 2021-35.1%-34.4%-40.5%
Q2 2020+5.1%
Q1 2021+5.1%
Q4 2020+5.1%
Q2 2021-13.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro